Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TOP2A | P11388 | 4/20 | 0.33 |
| ▸ | TOP2B | Q02880 | 4/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL141300 | 1.00 | ADRB2 (0.43) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL139825 | 0.90 | ADRB2 (0.44) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL146240 | 0.90 | ADRB2 (0.44) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL140444 | 0.90 | ADRB2 (0.44) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL143670 | 0.90 | ADRB2 (0.44) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL114940 | 0.89 | ADRB2 (0.47) | ADRB2STAT3TOP2ATOP2BKCNH2 | |
| SCHEMBL147194 | 0.89 | ADRB2 (0.45) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL145193 | 0.89 | ADRB2 (0.45) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL144078 | 0.86 | ADRB2 (0.44) | ADRB2STAT3MEN1KMT2ATOP2A | |
| SCHEMBL115076 | 0.86 | ADRB2 (0.47) | ADRB2STAT3KMT2ATOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058989-A1 | ANTIBACTERIAL FLUOROQUINOLONE ANALOGS | ACHAOGEN, INC. (US) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058989-A1 | ANTIBACTERIAL FLUOROQUINOLONE ANALOGS | RECQL, BLVRB, NQO2 | ADRB2 702/4885STAT3 4808/4885MEN1 3668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.